Page last updated: 2024-08-21

congo red and Autosomal Dominant Cerebellar Ataxia, Type II

congo red has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, N; Hide, I; Ogawa, K; Onji, T; Saito, N; Sakai, N; Seki, T; Takahashi, H; Tanaka, S; Yamamoto, K	1

Other Studies

1 other study(ies) available for congo red and Autosomal Dominant Cerebellar Ataxia, Type II

Article	Year
Congo red, an amyloid-inhibiting compound, alleviates various types of cellular dysfunction triggered by mutant protein kinase cγ that causes spinocerebellar ataxia type 14 (SCA14) by inhibiting oligomerization and aggregation. Journal of pharmacological sciences, 2010, Volume: 114, Issue:2 Topics: Amyloid; Animals; Apoptosis; Cells, Cultured; Cerebellum; Coloring Agents; Congo Red; Dendrites; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Mice; Mice, Inbred ICR; Mutant Proteins; Mutation, Missense; Neuroblastoma; Neurodegenerative Diseases; Protein Kinase C; Purkinje Cells; Spinocerebellar Ataxias; Spinocerebellar Degenerations	2010

Article

Year

Congo red, an amyloid-inhibiting compound, alleviates various types of cellular dysfunction triggered by mutant protein kinase cγ that causes spinocerebellar ataxia type 14 (SCA14) by inhibiting oligomerization and aggregation.

Journal of pharmacological sciences, 2010, Volume: 114, Issue:2

Topics: Amyloid; Animals; Apoptosis; Cells, Cultured; Cerebellum; Coloring Agents; Congo Red; Dendrites; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Mice; Mice, Inbred ICR; Mutant Proteins; Mutation, Missense; Neuroblastoma; Neurodegenerative Diseases; Protein Kinase C; Purkinje Cells; Spinocerebellar Ataxias; Spinocerebellar Degenerations

2010